Document is current
Any future updates will be listed below
-
Authors
Wu, Zhixian
Huang, Shulin
Li, Shasha
Cai, Jinquan
Huang, Lianghu
Wu, Weizhen
Chen, Jin
Tan, Jianming https://orcid.org/0000-0001-6968-4445
- License Information
-
More Information
Article History
Received: 10 April 2024
Accepted: 26 August 2024
First Online: 30 September 2024
Declarations
:
: All patients gave signed informed consent, and the study was approved by the institute review board (Board Name: IRB00006161 - Fuzhou General Hospital IRB #1). The study, titled “MSC and MC in Type 2 diabetes,” has been registered with clinicaltrials.gov (NCT01719640) and received project approval on November 1, 2012. The study was conducted in compliance with the principles of the Declaration of Helsinki and the International Conference on Harmonization Good Clinical Practice Guidelines and local regulatory requirements. Experimental bone marrow is harvested from healthy donors through a bone marrow aspiration procedure.
: Not applicable.
: The authors have no commercial, proprietary or financial interest in the products or companies described in this article.
